(Q35841464)

10 August 2017

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation (English)

1 reference

cost-effectiveness analysis

10 August 2017

0 references

1 reference

ChEBI release 2020-05-28

ChEBI ID

70746

1 reference

1 reference

7

Martin R Cowie

1 reference

10 August 2017

Anuraag R Kansal

1

1 reference

10 August 2017

Sonja V Sorensen

2

1 reference

10 August 2017

Ray Gani

3

1 reference

10 August 2017

Paul Robinson

4

1 reference

10 August 2017

Feng Pan

5

1 reference

10 August 2017

Jonathan M Plumb

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

10 August 2017

1 reference

10 August 2017

98

1 reference

10 August 2017

573-578

1 reference

10 August 2017

7

1 reference

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Dabigatran versus warfarin in patients with atrial fibrillation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Effect of study setting on anticoagulation control: a systematic review and metaregression

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Population-based study of acute- and long-term care costs after stroke in patients with AF.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3308473

Newly identified events in the RE-LY trial

24 September 2018

1 reference

12 December 2020

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

1 reference

12 December 2020

Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation

1 reference

12 December 2020

Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation

1 reference

12 December 2020

The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life

1 reference

12 December 2020

10.1136/HEARTJNL-2011-300646

Identifiers

DOI

1 reference

release_objlfz2psnh6hb5z6qtvfkvbsy

10 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/objlfz2psnh6hb5z6qtvfkvbsy

24 November 2022

mapped directly with Wikidata item

1 reference

10 August 2017

1 reference